The FDA granted Regenerative Medicine Advanced Therapy designation to NXC-201 for the treatment of relapsed/refractory light ...

A Cavan woman battling a rare and incurable form of bone marrow cancer hopes to run her 600th lifetime marathon by June of ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease MACHINE LEARNING MODEL USING ...

It was enjoyable watching the celebration in Boulder a few Sundays ago. Former CU coaches, players, staff, administrators and fans celebrate ...

A TERMINALLY-ill chef has vowed to run her 600th marathon by the summer. Doctors diagnosed Brenda O’Keeffe, 48, from Co Cavan, with a rare and untreatable type of bone marrow cancer last year. The ...

A 65-year-old man presented to the ED with 1 day of acute onset mid-thoracic and low back pain, difficulty ambulating and ...

With the first amyloid-targeting drug now approved for Alzheimer’s disease, Alnylam has presented preliminary clinical results with a new candidate that could potentially be dosed as ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

Family flowers only please, donations preferred in memory of Alan for Alzheimer's Research UK c/o The Funeral Director or ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...